No photo of Jonathan H Schatz

View Scopus Profile

Jonathan H Schatz

  • 956 Citations
  • 12 h-Index
20062019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Neoplasms Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Phosphotransferases Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
T-Cell Lymphoma Medicine & Life Sciences
Anaplastic Large-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2019

A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose

Schatz, J. H.

National Institutes of Health

9/19/14 → 8/31/19

Project: Research project › Research Project

Oncogenes
Neoplasms
Phosphotransferases
Therapeutics
Anaplastic Large-Cell Lymphoma

Research Output 2006 2018

  • 956 Citations
  • 12 h-Index
  • 24 Article
  • 1 Comment/debate
  • 1 Editorial

EIF4A inhibition: Ready for primetime?

Cunningham, T. A., Chapman, E. & Schatz, J. H., Oct 1 2018, In : Oncotarget. 9, 85, p. 35515-35516 2 p.

Research output: Contribution to journal › Editorial

Drug Discovery
1 Citations

Statins enhance efficacy of venetoclax in blood cancers

Lee, J. S., Roberts, A., Juarez, D., Vo, T. T. T., Bhatt, S., Herzog, L. O., Mallya, S., Bellin, R. J., Agarwal, S. K., Salem, A. H., Xu, T., Jia, J., Li, L., Hanna, J. R., Davids, M. S., Fleischman, A. G., O'Brien, S., Lam, L. T., Leverson, J. D., Letai, A. & 2 othersSchatz, J. H. & Fruman, D. A., Jun 13 2018, In : Science Translational Medicine. 10, 445, eaaq1240.

Research output: Contribution to journal › Article

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Neoplasms
Oxidoreductases
Protein Prenylation
Apoptosis
2 Citations

Target-based screening against eIF4A1 reveals the marine natural product elatol as a novel inhibitor of translation initiation with in vivo antitumor activity

Peters, T. L., Tillotson, J., Yeomans, A. M., Wilmore, S., Lemm, E., Jimenez-Romero, C., Amador, L. A., Li, L., Amin, A. D., Pongtornpipat, P., Zerio, C. J., Ambrose, A. J., Paine-Murrieta, G., Greninger, P., Vega, F., Benes, C. H., Packham, G., Rodríguez, A. D., Chapman, E. & Schatz, J. H., Sep 1 2018, In : Clinical Cancer Research. 24, 17, p. 4256-4270 15 p.

Research output: Contribution to journal › Article

Biological Products
Neoplasms
DEAD-box RNA Helicases
Heterografts
Adenosine Triphosphatases
1 Citations

Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study

Puvvada, S. D., Guillén-Rodríguez, J. M., Yan, J., Inclán, L., Heard, K., Rivera, X. I., Anwer, F. ., Mahadevan, D., Schatz, J. H. & Persky, D. O., Feb 22 2018, (Accepted/In press) In : Oncology (Switzerland).

Research output: Contribution to journal › Article

Radioimmunotherapy
Follicular Lymphoma
Non-Hodgkin's Lymphoma
Disease-Free Survival
Drug Therapy
3 Citations

A Phase II Exploratory Study of PXD-101 (Belinostat) Followed by Zevalin in Patients with Relapsed Aggressive High-Risk Lymphoma

Puvvada, S. D., Guillén-Rodríguez, J. M., Rivera, X. I., Heard, K., Inclan, L., Schmelz, M., Schatz, J. H. & Persky, D. O., Sep 5 2017, (Accepted/In press) In : Oncology (Switzerland).

Research output: Contribution to journal › Article

Lymphoma
Lymphoma, Large B-Cell, Diffuse
Major Histocompatibility Complex
Biomarkers
Histone Deacetylases